Maybe you are right ML I sincerely hope so as I do have a lot of...

Maybe you are right ML
I sincerely hope so as I do have a lot of skin in the game with IMU and have had since the 42c and" $1 party"
What doesn't sit easy with me is that
a) the previous cap raising was promoted to provide enough cash beyond AIPAC 2b results which if successful would not necessitate additional funds as we all know the likely outcome - t/o from big pharma.
And b) there was no hint even from the board at AGM or presentations that new capital was on the radar. At best poor communication with minority shareholders. I'm sure major shareholders would have been consulted before proceeding with latest cap raising.
"Marc please explain" why the cash runway needs to be extended well into 2020. Is there a delay in AIPAC recruitment and therefore delay in 2b results - now 2020 possibly? Are partner milestone payments forthcoming anytime soon? If not - why?
I've been a shareholder since well before the crazy 42c days and maintained a large position (for me) all the years since.
I do hope the light at the end of the tunnel is not the old empty $1 ghost train coming the other way. "toot toot"